Genomics | About

Introduction Genomics

About Genomics

Founded in 2001

"Genomics BioSci & Tech Co., Ltd (Genomics) was founded in 2001 by Dr. Zhou De Yian, a renowned Sequencing Researcher at the Academic Sinica, and his son, Joseph Chou, together with team of technology experts. We are the largest Commercial Genomic Company in Taiwan.
The company has committed significant efforts in the field of biological genetic sequencing for more than 20 years, and has accumulated various genomic analysis platforms and critical technology to provide researchers and medical institutions the most comprehensive technical services. We hope that by developing applications for genetic information, we can assist organizations in achieving breakthrough advances in their respective fields of research, and ultimately provide solutions to issues concerning human lives.
Starting from the basic genetic decoding technology, Genomics has been proactively participating in government-sponsored projects, such as the Cancer Moonshot project of the Academia Sinica, the establishment of the Taiwan Biobank, the Rapid WES Project, and the Taiwan Precision Medicine Initiative (TPMI). We utilize the experiences gained by our team and academic knowledge to integrate the genetic decoding platforms, leverage Big Data and AI technologies to development genetic engineering applications like the Swine Performance Testing Technology, making significant stride into the genomic application market."

We also provide the raw materials for nucleic acid and peptide pharmaceutics in the era of precision medicine, patching up the gaps in supply of raw materials to Taiwan’s biotechnology and R&D industry.

"As the COVID-19 pandemic broke out in 2020, Genomics cooperated with national policies to rapidly provide primers needed for PCR tests. Upon examining issues faced by Taiwan’s vaccine industry such as lack of critical technologies and raw materials, we made the decision to invest in the GMP oligonucleotide production industry, increasing our capacity for synthesis of nucleic acid probes and provide the raw materials for nucleic acid and peptide pharmaceutics in the era of precision medicine, patching up the gaps in supply of raw materials to Taiwan’s biotechnology and R&D industry.
In the coming years, Genomics will continue to introduce the latest genomic analysis platforms and technology, dedicating efforts into the development of genomic sequencing for technological services and clinical medicine market, while crossing over into the field of CDMO industry to complement scientific research with medical applications. We hope to steadily perfect the testing technology and key pharmaceutical molecules needed for precision medicine, and to assume the role of the critical supplier of medical services and systems. Whether it’s basic scientific research or clinical testing, Genomics is always your strongest ally; “Providing Fast and High Quality Services” is our unwavering vision and mission."

Key leadership figures: introduction to the founders of Genomics

Dr. De Yuan CHOW & President Meng Xian CHOW (Joseph Chow)

Dr. De Yuan CHOW

Pioneer of DNA Sequencing in Taiwan

Leads the Biotechnology industry in Taiwan to thrive and flourish globally

Dr. CHOW was mentored by Dr. Fred Sanger, the two-times Nobel Prize Laureate and inventor of DNA sequencing; Dr. CHOW was invited to co-direct the “International Rice Genome Sequencing Project” (IRGSP) and completed the sequencing of the 5th chromosome of Rice in 2005, putting Taiwan (R.O.C.)’s flag on the Rice chromosome map along with the United States and Japan and garnering worldwide attention.  Dr. Takuji Sasaki, convener of the IRGSP in Japan, also gave high praises to Dr. CHOW, believing his technique to be the “Gold Standard”.  As a way to contribute his learning, Dr. CHOW introduced the DNA sequencing technology into Taiwan and focused on the development and promotion of DNA sequencing technology, while owning various patents and publishing journal articles in respectable international journals such as Nature.  To ensure that the DNA sequencing technology is passed on and ever-evolving, Dr. CHOW and his Son, Joseph Chou, founded the GenoGenomics BioSci & Tech. Co.,Ltd. in 2001, hoping to lead the biotechnology industry in Taiwan to thrive and flourish on a global scale.

Education & Experience

Education and Experience

Ph.D. in Chemistry, The University of Manchester, United Kingdom
Founder of Genomics BioSci & Tech. Co., Ltd.
Research Fellow, Institute of Plant and Microbial Biology, Academia Sinica
Chair, Academic Sinica Plant Genome Center (ASPGC)
Jointly-appointed Professor, Institute of Plant Biology, National Taiwan University
Chair Professor, Graduate Institute of Biotechnology and Biomedical Engineering, Central Taiwan University of Science and Technology
University Committee Member, Ministry of Education and Outstanding Researcher award recipient of the National Science and Technology Council
Associate Research Fellow, Institute of Plant and Microbial Biology, Academia Sinica
Assistant Research Fellow, Institute of Plant and Microbial Biology, Academia Sinica
Teaching Assistant, School of Life Science, National Taiwan Normal University

MAJOR WORKS

Key Publications

International Rice Genome Sequencing Project. Academia Sinica Plant Genome Center (ASPGC)
Chow, T. Y., Chow, H. H., Chung, M. C. Chen, C. S., Wu, H. P. Hsiao, K. J., Chao, Y. T., Chu, M. K., Cheng, C. H.,Hour, A. L., Lee, P. F., Lin, S. J., Lin, Y. C., Liou, J. Y., Liu, S. M., and Hsing, Y. I. 2005.
The map-based sequence of the rice genome. Nature 436,793-800.
Ueguchi-Tanaka, M., Ashikari, M., Nakajima, M., Itoh, H., Katoh, E., Kobayashi, M., Chow, T.Y., Hsin,Y.I., Kitano, H.,Yamaguchi, I., and Matsuoka, T. 2005.
Gibberellin insensitive dwarf1 encodes a soluble receptor for gibberellin. Nature 437, 693-698.
Cheng, C. H., Chung, M. C., Liu, S. M., Chen, S. K., Kao, F. Y., Tseng, l. C., Hsing, Y. C., Wu, H. P., Chen, C. S.,Shaw, J. F., Wu, J., Sasaki, T., Chen, H. H., and Chow, T. Y. 2005.
A fine physical map of the rice chromosome 5. Molecular Genetics and Genomics 274, 337-345.
Chao, Y. T., Chen, C. S., Chen, H. H., Chow, T. Y., Chu, M. K., Hour, A. L., Hsing, Y. I. C., Lee, H. F., Lee, P. F., Lin,Y. C., Shaw, J. F., Su, C. L., Wei, F. J., and Wu, H. P. 2005.
Completing the decoding of rice chromosome 5. Journal of Genetics and Molecular Biology 16, 198-210.Kao, F. Y., Cheng, Y. Y., Chow, T. Y., Chen, H. H., Liu, S. M., Cheng, C. H., and Chung, M. C. 2006.
An integrated Molecular cytogenetic map of the Oryza sativa chromosome 5. Theoretical and Applied Genetics 112,891-902.

Achievements

Click on the image to enlarge and view details.

Rice sequencing research team

"Third from the left, front row: Dr. CHOW De Yuan, Founder of Genomics
Far left, front row:
Joseph Chou, Co-founder and President of Genomics"

When the draft of the rice genome sequence was completed, former President Chen has provided congratulatory words in both Chinese and English, and was read to the public by Dr. CHOW during the celebration party of sequence completion (December 28, 2002).

CHOW MENG XIAN

President (Founder)

Founded Genomics BioSci & Tech. Co.,Ltd.

To ensure that the DNA sequencing technology is passed on and ever-evolving, Dr. CHOW and his Son, Joseph Chou, founded the GenoGenomics BioSci & Tech. Co.,Ltd. in 2001, hoping to lead the biotechnology industry in Taiwan to thrive and flourish on a global scale.

EXPERIENCE

Experience

Vice President, Genomics BioSci & Tech. Co.,Ltd.
Board of Directors Member, Genomics BioSci & Tech. Co.,Ltd.
Vice President, PharmiGene
General Manager, PharmiGene
Research assistant, IGRSP, Academia Sinica

EDUCATION

Education

中國文化大學地理系 (2022年文化大學傑出校友)

Company history

Company History and Founding of Genomics in the year 2001

Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 with the vision to lead the biotechnology industry in Taiwan to thrive and flourish on a global scale.

2001

Now

More +

Company history

Genomics has the most comprehensive sequencing platforms, well-experienced laboratory teams, and strong bioinformatic analytical talents

2024

Signing of an exclusive agency contract with Thermo Fisher for the Taiwan Region.

2023

Founded the pharmaceutical biotechnology subsidiary - Lightest Biomedical Co., Ltd.
GMP plant received ISO 9001 certification.
GMP plant received Medical Device Good Distribution Practice certification.
Obtained grant support from the MoEA’s Taiwan Industry Innovation Platform Program.

Vaccine adjuvant production and functional testing.

2022

Constructed the first CDMO plant in Taiwan focused on providing short-chain nucleic acids and small-volume, large-variety production of peptides
Installed the TSO500 cancer genetic assay platform for comprehensive precision cancer genetic testing
Installed the first Illumina NovaSeq X Plus high-throughput next-generation sequencer in Taiwan.

Realized the building of Taiwan-based high-throughput testing capacity
GMP plant received Pharmacist Manufacturing License

2021

Introduced the Olink Proteomic assay technology

Expanded multiomic service items

2020

Update the brand image design of Genomics
Opportunity Biotech Co., Ltd, a spin-off of Genomics that is focused on agricultural development.

2019

Completed the MoEA’s Taiwan Industry Innovation Platform Program project: “Development of Swine Performance Testing Technology with Genome-wide Association Study (GWAS)”
Commenced operation of NovaSeq 6000
Participated in the Rapid WES Project.

Completing clinical diagnosis of rare diseases at four times the speed.
Participated in the Taiwan Precision Medicine Initiative.

Assisted in the Blood DNA extraction from over 500,000 subjects.

2018

Participated in the Cancer Moonshot Initiative as part of Academia Sinica’s “Development and Analysis of human genome next generation sequencing”.

Generated 68TB of data from 330 subjects.

2017

Participated in the Academia Sinica’s Taiwan Biobank Program.

Generated 145T of data from 1,783 subjects.

2016

Merge & acquired PharmiGene and entered the drug injury genetic testing market

2015

Tea and Orchid Species Identification Project.

2014

Constructed V3.0 of Core Laboratory

Established human whole genome, plants and animals genome, microbiological genome and functional medicine testing items.
Established Gen1, Gen2 and Gen3 sequencing platforms.

2013

Genomics (4195) registered as Emerging Stocks

Genomics (4195) went Public Offering in September and registered as Emerging Stocks in December.
Completed the genetic decoding of Formosan salmon.

Collaboration with National Taiwan Ocean University and MiTac Information Technology Corp.
Entered the NIPT market

2012

Established the largest genomic core laboratory V2.0 in Taiwan.

Introduced the three major genomic sequencing platforms and constructed the Metabolome spectrum laboratory.

2010

Genomics’ laboratory received TAF(ISO 17025) certificate and international certification mark.

2009

Constructed the genomic core laboratory V1.0.

Increased equipment installations and relocated the plant to the Oriental Science Park at Xizhi.
Became a Contracted Long-term Supplier of sequencing for the Genomic Research Center of Academia Sinica (from 2009 to present)
Started to offer next generation genomic sequencing services

2008

Entered the genetic testing market.

Integrated genetic testing technologies to provide preventive medical genetic testing services.

2004

Established [Online Ordering System] to effectively introduce the company’s business affairs into the web platform.

2003

Installed the automated high-speed sequencer (ABI 3730xl).
Became a Contracted Long-term Contractor for the CDC (from 2003 to present).

2001

Founded Genomics BioSci & Tech. Co.,Ltd.

Genomics was founded by Dr. CHOW De Yuan with core members of the Academia Sinica’s Rice Genome Project .

Top

goldennet

Introduction Genomics

About Genomics

Key leadership figures: introduction to the founders of Genomics